MiddleBrook Pharmaceuticals, Inc. Watch

from 8-K 42 pages Loan and Security Agreement

from 8-K 3 pages Reference Is Made to That Certain Credit and Security Agreement Dated June 30, 2006 (As Amended, Modified, Restated or Supplemented From Time to Time, the “Credit Agreement”) Between MiddleBrook Pharmaceuticals, Inc., F/K/a Advancis Pharmaceutical Corporation (“Borrower”), and Merrill Lynch Capital, a Division of Merrill Lynch Business Financial Services Inc., Individually as a Lender and as Agent (“Merrill Lynch”). All Capitalized Terms Used Herein and Not Defined Herein Shall Have the Meaning Ascribed to Such Terms in the Credit Agreement

from 10-Q 61 pages Credit and Security Agreement

from S-1/A ~50 pages Credit Agreement